THE CHARACTERIZATION OF A HEMOLYMPH METHYL FARNESOATE BINDING-PROTEINAND THE ASSESSMENT OF METHYL FARNESOATE METABOLISM BY THE HEMOLYMPH AND OTHER TISSUES FROM PROCAMBRUS-CLARKII
Le. King et al., THE CHARACTERIZATION OF A HEMOLYMPH METHYL FARNESOATE BINDING-PROTEINAND THE ASSESSMENT OF METHYL FARNESOATE METABOLISM BY THE HEMOLYMPH AND OTHER TISSUES FROM PROCAMBRUS-CLARKII, Insect biochemistry and molecular biology, 25(4), 1995, pp. 495-501
The haemolymph of Procambrus clarkii does not contain detectable level
s of methyl farnesoate esterase activity. Homogenates of the hepatopan
creas and the vas deferens contain significant methyl farnesoate ester
ase activity which is sensitive to inhibition by diisopropylfluorophos
phate. This activity may not be specific to methyl farnesoate since no
nspecific esterase activity is also inhibited by diisopropylfluorophos
phate. A methyl farnesoate binding protein, 93 +/- 3 kDa MW, has been
identified in the haemolymph using the photoaffinity analog [H-3]FDK a
nd both native and SDS-PAGE. The binding kinetics of this protein were
characterized with [H-3] methyl farnesoate and the K-d for methyl far
nesoate was found to be 320 +/- 150 nM.Competition experiments demonst
rated that this protein has a higher affinity toward methyl farnesoate
than farnesoic acid or juvenile hormone III and is therefore a methyl
farnesoate binding protein.